Although the reasons for this are unclear, TNBC is known to be more molecularly heterogeneous than ER+ BC, potentially resulting in a single core biopsy unlikely to encapsulate heterogenous PD-L1 expression19,20. The gene discussed is ESR1; the disease is breast cancer.